Abstract
Background Buprenorphine dependence is a relatively novel addiction.
Aims To compare the treatment outcome in three groups over 12-weeks of treatment.
Methods Two hundred and four intravenous (IV)-buprenorphine-dependent patients were randomised into three groups. Subjects received 50mg oral methadone tablet, or 5mg sublingual buprenorphine tablet, or 50mg oral naltrexone, and a weekly 30-minute clinical counselling session.
Results The majority (80%) had a history of opium or heroin dependency before they were introduced to IV buprenorphine. The main source of buprenorphine for misusers was street sale (91%). The mean duration of buprenorphine dependence was 1.9 years and the mean dose per day was 3.9 ampoules (1 ampoule contains 0.3mg of buprenorphine in 1ml). Overall 59% of the patients completed the 12-week study. Retention in the 50mg methadone group was significantly better than the 5mg dose buprenorphine group (p=0.001) and the 50mg dose naltrexone group (p=0.000). Retention in the 5mg buprenorphine group was significantly better than the 50mg naltrexone dose group (p=0.000).
Conclusions These results support the efficacy and safety of oral methadone and sublingual buprenorphine tablets for injection buprenorphine-dependent patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bickel WK, Stitzer ML, Bigelow GE et al. A clinical trial with buprenorphine: comparison with methadone in the detoxification of heroin addicts.Clin Pharmacol Tther 1988; 43: 72–8.
Johnson RE, Cone EJ, Henningfield JE et al. Use of buprenorphine in the treatment of opiate addiction. Physiologic and behavioral effects during a rapid dose induction.Clin Pharmacol Ther 1989; 46: 335–43.
O’Connor JJ, Maloney E, Travers R et al. Burprenorphine abuse among opiate addicts.Br J Addiction 1988; 83: 1085–87.
Basu D, Malhotra AK, Varma VK. Buprenorphine dependence: a new addiction in India.Disabilities and Impairments 1990; 3: 142–6.
Singh RA, Mattoo SK, Malhotra A et al. Cases of buprenorphine abuse in India.Acta Psychiatrica Scandinavica 1992; 86: 46–8.
Umesh Babu SB, Chaturvedi SK. Changing patterns of opiate abuse with a focus on buprenorphine.Indian J Psychiat 1995; 37: (suppl) 23.
Kumar MS. A study of buprenorphine abuse in Madras city, India. In exploratory studies on drug abuse in the Asian region; Navaratnam V. Devi V. Eds: International Monograph Series No. 10. University Sains Malaysia: Penang, 1997; 49–69
Sharma Y, Matoo SK. Burprenorphine abuse in India: an update.Indian J Psy 1999; 41: 154–9.
Harper I. Temgesic abuse.NZ Med J 1983; 96: 777.
Strang J. Abuse of buprenorphine.Lancet, ii 1985; 725.
Quigly AJ, Bredmeyer DE, Seow SS. A case of buprenorphine abuse.Med J Aust 1984; 140: 425–6.
Ahmed SK, Ara N. An exploratory study of buprenorphine use in Bangladesh: a note.Substance use & Misuse 2001; 36 (8): 1071–83.
Obadia Y, Perrin V, Feroni I et al. Injecting misuse of buprenorphine among French drug users.Addiction 2001; 96: 267–72.
Basu D, Mattoo SK, Malhotra A et al. A longitudinal study of male buprenorphine addicts attending a clinic in India.Addiction 2000; 95: 1363- 72.
Rainey HB. Abuse of buprenorphine.NZ Med J 1986; 99: 72.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ahmadi, J., Ahmadi, K. Controlled trial of maintenance treatment of intravenous buprenorphine dependence. Ir J Med Sci 172, 171–173 (2003). https://doi.org/10.1007/BF02915283
Issue Date:
DOI: https://doi.org/10.1007/BF02915283